Sleep disruption is no longer just about falling asleep. The real breakdown happens across the night, where restorative sleep cycles are fragmented or cut short.

Today’s consumer isn’t asking, “Did I sleep?”

They’re asking, “Did my sleep restore me?”

Traditional approaches weren’t built to solve that problem:

1. Prescription sleep medications: Often linked to dependency, next-day grogginess, and cognitive side effects.
2. Basic melatonin supplements: Single-release dosing that wears off before the night is complete.
3. OTC sleep aids: Frequently antihistamine-based, sedating the body rather than supporting natural sleep cycles.

Demand is shifting toward solutions that support deep sleep, reduce interruptions, and address condition-specific disruptors such as menopause symptoms, prostate-related wake events, stress, and circadian misalignment.

The science is clear. Restorative sleep depends on maintaining balanced REM and deep sleep cycles across the full night, not just initiating sleep. (source)

Our Solution: The Science of Better Sleep

Understanding Sleep Architecture

Sleep is not a single state. It is a structured biological cycle your body must move through repeatedly for full restoration:

1. Stage 1 & 2 (Light Sleep): Initial relaxation and transition phases
2. Stage 3 & 4 (Deep Sleep): Critical for physical restoration, immune function, and hormone regulation
3. REM Sleep: Essential for cognitive performance, memory consolidation, and emotional processing.

Most conventional sleep aids interrupt this architecture by sedating the brain instead of supporting the body’s natural progression through these stages.

NightWise's Patented 3-Phase Intelligent Release Technology® for Restorative Sleep

NightWise was built to align with sleep biology, not override it.

Developed by industry veteran Scott Forsberg, former executive formulator behind hundreds of commercial products, our patented multi-phase delivery system releases ingredients in synchronized waves designed to support the body’s natural sleep cycle across the night.

Rather than a single dose that fades, Intelligent Release Technology® works in three coordinated phases:

1. Initiates sleep onset
2. Sustains sleep continuity
3. Supports restorative cycle depth

Product Line: A Platform, Not Just a Product

NightWise was built as a functional sleep platform, not a single-product brand.

Our core formulation serves as the architectural foundation for a portfolio of targeted sleep solutions designed to address specific root causes of sleep disruption across modern consumers.

Rather than chasing adjacent categories, we are expanding within sleep itself, where unmet need and repeat purchase behavior are structurally high.

This platform approach enables:

1. Multiple condition-specific SKUs built on a shared technology backbone
2. Diversified revenue streams within one category
3. Higher lifetime value per customer
4. Expanded retail shelf relevance across subsegments

Each product extension strengthens the overall system rather than diluting brand focus.

These specialized products create multiple revenue streams and address underserved segments of the sleep market.

Protected by Multiple Patents

NightWise® innovation is not just formulated. It is protected.

Our intellectual property portfolio creates structural barriers to entry around both delivery technology and brand equity, reinforcing long-term competitive defensibility.

1. US Patent 11,351,150: Time-release sleep aid system
2. US Patent 11,890,271: Phased-release formulation for comprehensive sleep support
3. U.S. Reg. No. 7007208: INTELLIGENT RELEASE TECHNOLOGY
4. U.S. Reg. No. 6512271: NIGHTWISE

These patents and trademarks create a protected moat around our technology, ensuring our competitive advantage for years to come while building significant company valuation.

Our Way of Saying “Thank You”

From Personal Struggle to Helping Thousands Sleep Better

NightWise began with a problem that was personal before it was commercial.

Frequent business travel left our founder, Danny Rinaldi, in a constant state of sleep deprivation. Like millions of Americans, he found himself relying on solutions that either left him groggy the next day or failed to sustain sleep through the night.

What started as frustration quickly became curiosity. And curiosity turned into conviction.

In his own basement, Danny personally bottled the first 1,000 units of NightWise® on a single Saturday — driven by the belief that better sleep should not come with dependency, sedation, or next-day impairment.

That early effort was never meant to stay small. It was the beginning of a larger mission: to modernize how sleep is supported in an era where performance, recovery, and long-term health are more important than ever.

Despite universal demand, the sleep aid category had seen little structural innovation for decades. Recognizing the need for scientific partnership, Danny joined forces with leading nutraceutical scientist Scott Forsberg, whose formulation leadership helped shape some of the industry’s most recognized supplement brands.

Together, they developed NightWise® — a multi-ingredient, controlled-release, drug-free sleep system designed to align with the body’s natural sleep rhythms rather than override them.

That foundational work has since translated into commercial traction, including more than $250,000 in direct-to-consumer revenue and early-stage retail discussions spanning over thousands of store locations.

What began as one founder’s sleep struggle has evolved into a platform built to help millions experience restorative sleep at scale.

Market Validation Results

Our initial testing phase has provided measurable outcomes:

1. $250K+ DTC revenue traction
2. High repeat purchase rates
3. 4.8★ customer rating
4. 61% COGS reduction
5. Margin structure strengthened
6. Retail-ready price repositioning
7. Accessible under-$20 price point
8. Scalable platform unit economics
9. $137B global category growth

The global sleep market size to reach USD 137.16 billion by 2026, growing at a CAGR of 6.11% during the forecast period (source). We believe NightWise® is positioned to capture a significant slice of this expanding market.

Expanding the Category Without Cannibalizing It

NightWise® isn’t built to displace the existing sleep aisle. It’s built to expand it by activating consumers underserved by traditional solutions:

✅Unlocks incremental demand beyond melatonin and OTC sedatives

✅ Re-engages consumers who abandoned legacy sleep aids

✅ Delivers restorative outcomes, not sedation-based effects

✅ Builds trust through clean-label, science-backed formulations

By recruiting new shoppers rather than replacing existing ones, NightWise® positions retailers to grow category revenue while modernizing the sleep set for today’s consumer expectations.

Retail Expansion Strategy

NightWise® is executing a retail-first expansion strategy anchored in digital velocity and performance-driven buyer activation.

We begin with Walmart Marketplace as our national digital launch partner. This phase is designed to generate real-time shopper conversion data, repeat purchase behavior, and retail media performance signals within the largest mass retail ecosystem in the United States.

From there, success inside Walmart’s digital environment accelerates in-store retail expansion. Marketplace velocity, supported by Walmart Connect retail media, creates a structured pathway into physical shelf placement.

This model allows NightWise® to enter brick-and-mortar retail not as a speculative brand, but as a performance-validated platform with proven demand and measurable sell-through.

Following Walmart, expansion extends outward across grocery, drug, and club channels through a sequenced door growth roadmap supported by broker infrastructure and retail media investment.

The result is a capital-efficient retail scale strategy designed to convert digital performance into national physical distribution.

Use of Funds: $600,000 for Exponential Growth

Why Invest Now

Platform validation completed: Revenue traction and repeat purchase behavior established

Patented technology moat: Multi-phase delivery system protected by issued IP

Retail acceleration underway: Walmart Marketplace launch driving national expansion pathway

Platform portfolio scaling: Condition-specific SKUs expanding revenue per customer

Improving unit economics: COGS reductions strengthening margin profile

Strategic exit alignment: Built for acquisition by CPG or consumer health leaders

This is the inflection point where validated science, retail scale, and consumer demand converge.